Lennox-Gastaut syndrome caused by CHD2 gene de novo variation: three cases report and literature review

doi:10.3969/j.issn.1672-6731.2025.11.006

Abstract

Abstract: Objective To report clinical characteristics of Lennox-Gastaut syndrome (LGS) caused by CHD2 gene de novo variation. Methods and Results Three children with LGS admitted to Peking University People's Hospital from June 2023 to May 2024 were enrolled. Their onset ages were 3 months, 3 years and 4 months, and 3 years and 5 months, respectively. All 3 cases were transformed from infantile spasms (IS), presenting with spasm epileptic seizures, tonic seizures and global developmental delay. EEG initially showed hypsarrhythmia, which later progressed to generalized and multifocal discharges during disease progression. Whole exome sequencing (WES) revealed a missense variant c. 2740C > T (p. Arg914Cys) in Case 1, a nonsense variant c. 806C > G (p. Ser269*) in Case 2, and a missense variant c.2492A > C (p.His831Pro) in Case 3; neither parent carried the same type of variation, all variants were de novo. Three patients received antiepileptic seizure medicine (ASM), and at the last follow-up, seizures remained uncontrolled in all patients. Conclusions LGS caused by CHD2 gene variation typically present in childhood, often with delayed motor and language development. Most patients have uncontrollable seizures that are often resistant to medication.

Key words: Lennox Gastaut syndrome, Epilepsy, Genes, Mutation, Child, preschool

摘要： 目的报道3例CHD2基因新发变异致Lennox-Gastaut综合征患儿，总结其临床和遗传学特征。方法与结果 选择北京大学人民医院2023年6月至2024年5月收治的3例Lennox-Gastaut综合征患儿，发病年龄分别为3个月、3岁4个月和3岁5个月，均为婴儿痉挛症进展为Lennox-Gastaut综合征，均存在痉挛发作、强直发作及全面发育迟缓；脑电图呈高度失律，随病情进展表现为广泛性及多灶性放电。全外显子组测序显示，例1存在CHD2基因c.2740C > T（p.Arg914Cys）错义突变，例2存在CHD2基因c.806C > G（p.Ser269*）无义突变，例3存在CHD2基因c.2492A > C（p.His831Pro）错义突变，父母均未携带同型突变，均为新发突变。予以抗癫痫发作药物，其中例3同时予生酮饮食，但均未控制发作。结论 CHD2基因变异致Lennox-Gastaut综合征通常于儿童期发病，常伴运动、语言发育迟缓，多数癫痫发作难以控制。

关键词: 伦诺克斯综合征, 癫痫, 基因, 突变, 儿童，学龄前

NIU Yue, ZHOU Zong-pu, JIAO Xian-ru, XU Zhao, QIN Jiong, YANG Zhi-xian. Lennox-Gastaut syndrome caused by CHD2 gene de novo variation: three cases report and literature review[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2025, 25(11): 1012-1019.

牛悦, 周宗朴, 焦莶如, 徐兆, 秦炯, 杨志仙. CHD2基因新发变异致Lennox-Gastaut综合征三例并文献复习[J]. 中国现代神经疾病杂志, 2025, 25(11): 1012-1019.

/ / Recommend / Download Citations

URL: https://journal11.magtechjournal.com/cjcnn/EN/10.3969/j.issn.1672-6731.2025.11.006

https://journal11.magtechjournal.com/cjcnn/EN/Y2025/V25/I11/1012

References

[1] Guerrini R, Conti V, Mantegazza M, Balestrini S, Galanopoulou AS, Benfenati F. Developmental and epileptic encephalopathies:from genetic heterogeneity to phenotypic continuum[J]. Physiol Rev, 2023, 103:433-513.
[2] Kim SH, Seo J, Kwon SS, Teng LY, Won D, Shin S, Lee JS, Lee ST, Choi JR, Kang HC. Common genes and recurrent causative variants in 957 Asian patients with pediatric epilepsy[J]. Epilepsia, 2024, 65:766-778.
[3] Sullivan J, Benítez A, Roth J, Andrews JS, Shah D, Butcher E, Jones A, Cross JH. A systematic literature review on the global epidemiology of Dravet syndrome and Lennox-Gastaut syndrome:prevalence, incidence, diagnosis, and mortality[J]. Epilepsia, 2024, 65:1240-1263.
[4] Coppola A, Krithika S, Iacomino M, Bobbili D, Balestrini S, Bagnasco I, Bilo L, Buti D, Casellato S, Cuccurullo C, Ferlazzo E, Leu C, Giordano L, Gobbi G, Hernandez-Hernandez L, Lench N, Martins H, Meletti S, Messana T, Nigro V, Pinelli M, Pippucci T, Bellampalli R, Salis B, Sofia V, Striano P, Striano S, Tassi L, Vignoli A, Vaudano AE, Viri M, Scheffer IE, May P, Zara F, Sisodiya SM. Dissecting genetics of spectrum of epilepsies with eyelid myoclonia by exome sequencing[J]. Epilepsia, 2024, 65:779-791.
[5] Zhu L, Peng F, Deng Z, Feng Z, Ma X. A novel variant of the CHD2 gene associated with developmental delay and myoclonic epilepsy[J]. Front Genet, 2022, 13:761178.
[6] Chen J, Zhang J, Liu A, Zhang L, Li H, Zeng Q, Yang Z, Yang X, Wu X, Zhang Y. CHD2-related epilepsy:novel mutations and new phenotypes[J]. Dev Med Child Neurol, 2020, 62:647-653.
[7] Prince S, Bonkowski E, McGraw C, SanInocencio C, Mefford HC, Carvill G, Broadbent B. A roadmap to cure CHD2-related disorders[J]. Ther Adv Rare Dis, 2024, 5:1-16.
[8] Suls A, Jaehn JA, Kecskés A, Weber Y, Weckhuysen S, Craiu DC, Siekierska A, Djémié T, Afrikanova T, Gormley P, von Spiczak S, Kluger G, Iliescu CM, Talvik T, Talvik I, Meral C, Caglayan HS, Giraldez BG, Serratosa J, Lemke JR, Hoffman-Zacharska D, Szczepanik E, Barisic N, Komarek V, Hjalgrim H, Møller RS, Linnankivi T, Dimova P, Striano P, Zara F, Marini C, Guerrini R, Depienne C, Baulac S, Kuhlenbäumer G, Crawford AD, Lehesjoki AE, de Witte PA, Palotie A, Lerche H, Esguerra CV, De Jonghe P, Helbig I; EuroEPINOMICS RES Consortium. De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome[J]. Am J Hum Genet, 2013, 93:967-975.
[9] Pinto AM, Bianciardi L, Mencarelli MA, Imperatore V, Di Marco C, Furini S, Suppiej A, Salviati L, Tenconi R, Ariani F, Mari F, Renieri A. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation[J]. Brain Dev, 2016, 38:590-596.
[10] Thomas RH, Zhang LM, Carvill GL, Archer JS, Heavin SB, Mandelstam SA, Craiu D, Berkovic SF, Gill DS, Mefford HC, Scheffer IE; EuroEPINOMICS RES Consortium. CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures[J]. Neurology, 2015, 84:951-958.
[11] Zhou P, He N, Zhang JW, Lin ZJ, Wang J, Yan LM, Meng H, Tang B, Li BM, Liu XR, Shi YW, Zhai QX, Yi YH, Liao WP. Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies[J]. Genes Brain Behav, 2018, 17:e12456.
[12] Ko A, Youn SE, Kim SH, Lee JS, Kim S, Choi JR, Kim HD, Lee ST, Kang HC. Targeted gene panel and genotype-phenotype correlation in children with developmental and epileptic encephalopathy[J]. Epilepsy Res, 2018, 141:48-55.
[13] Symonds JD, Zuberi SM, Stewart K, McLellan A, O'Regan M, MacLeod S, Jollands A, Joss S, Kirkpatrick M, Brunklaus A, Pilz DT, Shetty J, Dorris L, Abu-Arafeh I, Andrew J, Brink P, Callaghan M, Cruden J, Diver LA, Findlay C, Gardiner S, Grattan R, Lang B, MacDonnell J, McKnight J, Morrison CA, Nairn L, Slean MM, Stephen E, Webb A, Vincent A, Wilson M. Incidence and phenotypes of childhood-onset genetic epilepsies:a prospective population-based national cohort[J]. Brain, 2019, 142:2303-2318.
[14] Lamar KJ, Carvill GL. Chromatin remodeling proteins in epilepsy:lessons from CHD2-associated epilepsy[J]. Front Mol Neurosci, 2018, 11:208.
[15] McTague A, Howell KB, Cross JH, Kurian MA, Scheffer IE. The genetic landscape of the epileptic encephalopathies of infancy and childhood[J]. Lancet Neurol, 2016, 15:304-316.
[16] Chourasia N, Yuskaitis CJ, Libenson MH, Bergin AM, Liu S, Zhang B, Poduri A, Harini C. Infantile spasms:assessing the diagnostic yield of an institutional guideline and the impact of etiology on long-term treatment response[J]. Epilepsia, 2022, 63:1164-1176.
[17] Capelli LP, Krepischi AC, Gurgel-Giannetti J, Mendes MF, Rodrigues T, Varela MC, Koiffmann CP, Rosenberg C. Deletion of the RMGA and CHD2 genes in a child with epilepsy and mental deficiency[J]. Eur J Med Genet, 2012, 55:132-134.
[18] Carvill GL, Heavin SB, Yendle SC, McMahon JM, O'Roak BJ, Cook J, Khan A, Dorschner MO, Weaver M, Calvert S, Malone S, Wallace G, Stanley T, Bye AM, Bleasel A, Howell KB, Kivity S, Mackay MT, Rodriguez-Casero V, Webster R, Korczyn A, Afawi Z, Zelnick N, Lerman-Sagie T, Lev D, Møller RS, Gill D, Andrade DM, Freeman JL, Sadleir LG, Shendure J, Berkovic SF, Scheffer IE, Mefford HC. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1[J]. Nat Genet, 2013, 45:825-830.
[19] Clara-Hwang A, Stefani S, Lau T, Scala M, Aynekin B, Bernardo P, Madia F, Bakhtadze S, Kaiyrzhanov R, Maroofian R, Zara F, Srinivasan VM, Gowda V, Guliyeva U, Montavont A, Poulat AL, Güleç A, Berger C, Ville DM, de Bellescize J, Cabet S, Wonneberger A, Schulz A, Rodriguez-Palmero A, Chatron N, Lesca G, Per H, Goel H, Brown J, Frey T, Steindl K, Rauch A, Severino M, Houlden H, Nicolaides P, Striano P, Efthymiou S. Expanding the mutational landscape and clinical phenotype of CHD2-related encephalopathy[J]. Neurol Genet, 2024, 10:e200168.
[20] Li BG, Wu WJ, Zheng HX, Yang HF. Clinical characteristics of epilepsy caused by CHD2 gene mutation in 9 cases[J]. Nao Yu Shen Jing Ji Bing Za Zhi, 2023, 31:278-281.[李宝广, 吴文娟, 郑会晓, 杨花芳. CHD2 基因突变致癫痫患者九例[J]. 脑与神经疾病杂志, 2023, 31:278-281.]
[21] Angelopoulou E, Theodosiou A, Papaevripidou I, Alexandrou A, Liehr T, Gyftodimou Y, Stefanou EG, Sismani C. CHD2 pathogenic nonsense variant in a three-generation family with variable phenotype and a paracentric inversion 16:case report[J]. Heliyon, 2023, 9:e22987.
[22] Galizia EC, Myers CT, Leu C, de Kovel CG, Afrikanova T, Cordero-Maldonado ML, Martins TG, Jacmin M, Drury S, Krishna Chinthapalli V, Muhle H, Pendziwiat M, Sander T, Ruppert AK, Møller RS, Thiele H, Krause R, Schubert J, Lehesjoki AE, Nürnberg P, Lerche H; EuroEPINOMICS CoGIE Consortium; Palotie A, Coppola A, Striano S, Gaudio LD, Boustred C, Schneider AL, Lench N, Jocic-Jakubi B, Covanis A, Capovilla G, Veggiotti P, Piccioli M, Parisi P, Cantonetti L, Sadleir LG, Mullen SA, Berkovic SF, Stephani U, Helbig I, Crawford AD, Esguerra CV, Kasteleijn-Nolst Trenité DG, Koeleman BP, Mefford HC, Scheffer IE, Sisodiya SM. CHD2 variants are a risk factor for photosensitivity in epilepsy[J]. Brain, 2015, 138(Pt 5):1198-1207.
[23] Lebrun N, Parent P, Gendras J, Billuart P, Poirier K, Bienvenu T. Autism spectrum disorder recurrence, resulting of germline mosaicism for a CHD2 gene missense variant[J]. Clin Genet, 2017, 92:669-670.
[24] Zhang XL, Wang MY, Zhang CY, Li JL, Ma YC, Wang JL, Li XL, Han R, Xu D, Jia TM. Clinical features and genetic characteristics of epilepsy associated with CHD2 gene variants[J]. Lin Chuang Er Ke Za Zhi, 2024, 42:121-126.[张晓莉, 王梦月, 张晨宇, 李佳霖, 马轶超, 王俊玲, 李小丽, 韩瑞, 徐丹, 贾天明. CHD2 基因相关癫痫的临床特点和遗传学分析[J]. 临床儿科杂志, 2024, 42:121-126.]

Please choose a citation manager

Content to export